Research across Kidney Diseases
Related studies from across the Kidney Diseases family.
37 trials tracked for Renal impairment: 1 in phase 3 or 4.
Showing the 37 most-cited and recently-updated of 37 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
In studies evaluating Tadalafil for renal-related outcomes, results regarding its impact on urinary sodium excretion were inconsistent. One trial showed no significant change in urinary sodium excretion (p=0.8) 4, while another study reported a statistically significant increase in urinary sodium excretion (p=0.04) 5.
Clinical evaluations of Tadalafil did not find significant changes in Glomerular Filtration Rate (GFR) (p=0.25) or Urinary Cyclic Guanosine 3',5'-Monophosphate (cGMP) Hormone Excretion (p=0.32) 4.
AI synthesis of 5 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Kidney Diseases family.